Attributes | Values |
---|
rdf:type
| |
description
| - wetenschappelijk artikel (nl)
- im September 2019 veröffentlichter wissenschaftlicher Artikel (de)
- artículu científicu espublizáu en setiembre de 2019 (ast)
- наукова стаття, опублікована 6 вересня 2019 (uk)
- scientific article published on 06 September 2019 (en)
|
publication date
| |
publication date
| |
author name string
| |
author name string
| - Ming Zhao
- Yaonan Wang
- Xiaoyi Zhang
- Wenchao Liu
- Yujia Mao
- Shurui Zhao
|
rdfs:label
| - RGDV-modified gemcitabine: a nano-medicine capable of prolonging half-life, overcoming resistance and eliminating bone marrow toxicity of gemcitabine (en)
- RGDV-modified gemcitabine: a nano-medicine capable of prolonging half-life, overcoming resistance and eliminating bone marrow toxicity of gemcitabine (nl)
|
skos:prefLabel
| - RGDV-modified gemcitabine: a nano-medicine capable of prolonging half-life, overcoming resistance and eliminating bone marrow toxicity of gemcitabine (en)
- RGDV-modified gemcitabine: a nano-medicine capable of prolonging half-life, overcoming resistance and eliminating bone marrow toxicity of gemcitabine (nl)
|
name
| - RGDV-modified gemcitabine: a nano-medicine capable of prolonging half-life, overcoming resistance and eliminating bone marrow toxicity of gemcitabine (en)
- RGDV-modified gemcitabine: a nano-medicine capable of prolonging half-life, overcoming resistance and eliminating bone marrow toxicity of gemcitabine (nl)
|
author
| |
author
| |
title
| |
title
| - RGDV-modified gemcitabine: a nano-medicine capable of prolonging half-life, overcoming resistance and eliminating bone marrow toxicity of gemcitabine (en)
|
page(s)
| |
page(s)
| |
instance of
| |
instance of
| |
PubMed ID
| |
PubMed ID
| |
PubMed ID
| |
published in
| |
published in
| |
volume
| |
volume
| |
DOI
| |
DOI
| |
DOI
| |
copyright license
| |
copyright status
| |
copyright license
| |
copyright status
| |
PMCID
| |
PMCID
| |
is about
of | |
is cites work
of | |
is cites work
of | |